DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
94. 原発性硬化性胆管炎
Primary sclerosing cholangitis
Clinical trials
/
Disease details
臨床試験数
:
148
/
薬物数
:
118
- (
DrugBank
:
39
) /
標的遺伝子数
:
18
-
標的パスウェイ数
:
141
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2019-001015-23-FR
(
EUCTR
)
13/05/2020
04/06/2020
Study evaluating the efficacy of bezafibrate for people suffering of primary sclerosing cholangitis
Double blind, multicentric, randomized, placebo-controlled trial, evaluating the efficacy of 24-month of bezafibrate in primary sclerosing cholangitis with persistent cholestasis despite ursodeoxycholic acid therapy - BEZASCLER
Double blind, multicentric, randomized, placebo-controlled trial, evaluating the efficacy of 24-mont ...
Adult patients with primary sclerosing cholangitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Adult patients with primary sclerosing cholangitis;Therapeutic area: Diseases [C] - Digestive System ...
Trade Name:
BEFIZAL
L.P. 400 mg, comprimé enrobé à libération prolongée
Product Name:
bezafibrate
Product Code:
C10AB02
INN or Proposed INN:
BEZAFIBRATE
Trade Name:
BEFIZAL
L.P. 400 mg, comprimé enrobé à libération prolongée
Product Name:
bezafibrate
Produ ...
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
104
Phase 3
France